Exploring the Potential of CAR T-Cell Therapy in Autoimmune Neurologic Diseases: Amanda Piquet, MD, FAAN
FDA Approves Medtronic's Adaptive DBS, Hold Lifted on ELEVATE-44-102 Trial, Ecopipam Meets Primary and Secondary End Points in Tourette
Paving the Way for Autoimmune Neurology Treatment With CAR T-Cell Therapy: Amanda Piquet, MD, FAAN
NeurologyLive® Friday 5 — February 28, 2025